Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Seeding Techniques in Crystallization – V 2.0

Posted on By

API Manufacturing: SOP for Seeding Techniques in Crystallization – V 2.0

Standard Operating Procedure for Seeding Techniques in Crystallization in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/062/2025
Supersedes SOP/API/062/2022
Page No. Page 1 of 10
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To define a standardized procedure for implementing seeding techniques in crystallization operations to control nucleation, improve crystal size distribution, and ensure batch consistency in API manufacturing.

2. Scope

This SOP is applicable to all API crystallization processes where seeding is used to induce or control crystallization in stirred tank reactors, crystallizers, and batch vessels.

3. Responsibilities

  • Production Operators: Prepare, introduce, and monitor seed slurry during crystallization as per batch record.
  • Production Supervisor: Ensure appropriate seed type and quantity are used and monitor critical parameters.
  • QC Department: Verify particle size and polymorph form of seed material (if applicable).
  • QA Department: Review documentation and approve the crystallization step.
See also  API Manufacturing: SOP for Storage of Hazardous and Flammable Materials - V 2.0

4. Accountability

The Production Head is accountable for ensuring proper execution of seeding operations. The QA Head is responsible for validating the process and records.

5. Procedure

5.1 Selection of Seeding Strategy

  1. Determine seeding requirement based on prior development reports or validation data.
  2. Select seed type:
    • Same API crystal form from previous batch or lab-prepared
    • Dry seed or seed slurry (as applicable)
  3. Ensure seed matches desired polymorph and particle size (as per CoA or microscopic check).

5.2 Preparation of Seed Slurry

  1. Weigh required quantity of dry seed (typically 0.1–1.0% w/w of theoretical API).
  2. Disperse seed in suitable mother liquor or solvent under stirring to form uniform slurry.
  3. Ensure temperature of slurry matches the crystallization mass (within ±5°C).
  4. Record preparation details in the “Seed Slurry Preparation Log” (Annexure-1).
See also  API Manufacturing: SOP for Vendor Qualification and Approval Process - V 2.0

5.3 Addition of Seed to Crystallizer

  1. Ensure crystallization mass has reached the seeding temperature (as per batch record).
  2. Add seed slurry slowly through charging port over 10–15 minutes under continuous stirring.
  3. Maintain agitation to distribute seed uniformly in the batch.
  4. Do not allow sudden cooling during or after seeding to avoid uncontrolled nucleation.

5.4 Post-Seeding Monitoring

  1. Monitor temperature, agitation, and crystal formation visually or using online probes (if available).
  2. Continue to cool the batch gradually as per the crystallization profile.
  3. Collect in-process sample for microscopy and pH, if required.
  4. Document entire seeding process in the batch record and “Seeding Process Monitoring Log” (Annexure-2).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • API: Active Pharmaceutical Ingredient
  • QC: Quality Control
  • QA: Quality Assurance
  • CoA: Certificate of Analysis

7. Documents

  1. Seed Slurry Preparation Log (Annexure-1)
  2. Seeding Process Monitoring Log (Annexure-2)
  3. Batch Manufacturing Record
See also  API Manufacturing: SOP for Use of Cooling Towers and Condensers in Recovery - V 2.0

8. References

  • ICH Q8 – Pharmaceutical Development
  • ICH Q7 – GMP for Active Pharmaceutical Ingredients
  • Internal Crystallization Validation Protocol

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Seed Slurry Preparation Log

Date Batch No. Seed Type Quantity (g) Solvent Prepared By
13/04/2025 CRY-20250413 API-A Seed 45 IPA

Annexure-2: Seeding Process Monitoring Log

Date Batch No. Seeding Temp (°C) Time RPM Observation Operator
13/04/2025 CRY-20250413 30 09:30 150 Crystal Initiation Noted

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP Release Process Qualification QA Head
13/04/2025 2.0 Introduced Annexures for Monitoring and Slurry Prep Audit Recommendation QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: BA-BE Studies: SOP for Volunteer Compensation and Reimbursement – V 2.0
Next Post: Aerosol: SOP for Revalidating Cleaning Processes After Modifications – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version